STAREE trial will give its verdict on primary prevention statins in people ages 70 and up
— STAREE trial will give its verdict on primary prevention statins in people ages 70 and up
by Nicole Lou, Senior Staff Writer, MedPage Today
August 26, 2026
• 3 min read
The European Society of Cardiology (ESC) meeting this week will unveil the latest findings in cardiovascular medicine, including a highly-anticipated statin trial and several studies poised to advance heart attack triage and care.
Cardiovascular benefits of primary prevention statins were evident even in healthy older adults
MUNICH — Statin therapy cut risk for major adverse CV events by 30% for healthy older adults compared with placebo, but did not…
A world-first clinical trial has found cholesterol-lowering medication significantly reduces the risk of a major cardiovascular…
Up to 21.5 million additional U.S. adults may be considered eligible for statin therapy based on newly updated dyslipidemia…
Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths, a new study finds.
Australian-led trial finds low risk of side effects from common cholesterol-lowering medication for otherwise healthy older people
Statins can safely cut risk of heart attacks or strokes in healthy people aged over 70, world-first clinical trial shows
